Xolair 75 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FNMXH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,737
Award facts
- Contract value 100% obligated
- $7,737.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a continuation of DMS Pharmaceutical Group's extensive pharmaceutical supply relationship with the Department of Defense. The award includes no set-aside designation, reflecting the vendor's competitive positioning in the federal marketplace.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026. The underlying contract, designated SPE2DB, enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare facilities worldwide. DMS Pharmaceutical Group's role as a critical supplier in the federal pharmaceutical supply chain encompasses branded and generic prescription drugs, biologics, vaccines, and specialty medications, with this particular order fulfilling immediate pharmaceutical needs for Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DB25FNMXH?
SPE2DB25FNMXH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FNMXH worth?
The government has obligated $7,737 on SPE2DB25FNMXH.
Is contract SPE2DB25FNMXH an order under another contract?
Yes. SPE2DB25FNMXH is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMXH competed?
The extent of competition for SPE2DB25FNMXH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award